Evidence map›Paper›PMID 27659693›Full record

ArticleScientific reports2016

Modulation of yeast telomerase activity by Cdc13 and Est1 in vitro.

Yu-Fan Chen, Chia-Ying Lu, Yi-Chien Lin, Tai-Yuan Yu, Chun-Ping Chang, Jing-Ru Li, Hung-Wen Li, Jing-Jer Lin

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yu-Fan ChenInstitute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan.
Chia-Ying LuInstitute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei 100, Taiwan.
Yi-Chien LinInstitute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan.
Tai-Yuan YuInstitute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan.
Chun-Ping ChangInstitute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei 100, Taiwan.
Jing-Ru LiDepartment of Chemistry, National Taiwan University, Taipei 100, Taiwan.
Hung-Wen LiDepartment of Chemistry, National Taiwan University, Taipei 100, Taiwan.
Jing-Jer LinInstitute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan.
National Taiwan University · TWNational Yang Ming Chiao Tung University · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomerase is the enzyme involved in extending telomeric DNA. Control of telomerase activity by modulating its access to chromosome ends is one of the most important fundamental mechanisms. This study established an in vitro yeast telomerase reconstitution system that resembles telomere replication in vivo. In this system, a tailed-duplex DNA formed by telomeric DNA was employed to mimic the structure of telomeres. The core catalytic components of telomerase Est2/Tlc1 RNA were used as the telomeric DNA extension machinery. Using the reconstituted systems, this study found that binding of Cdc13 to telomeric DNA inhibited the access of telomerase to its substrate. The result was further confirmed by a single-molecule approach using the tethered-particle motion (TPM)-based telomerase assay. The findings also showed that the inhibitory effect can be relieved by telomerase-associated protein Est1, consistent with the role of Cdc13 and Est1 in regulating telomere extension in vivo. Significantly, this study found that the DNA binding property of Cdc13 was altered by Est1, providing the first mechanistic evidence of Est1 regulating the access of telomerase to its substrate. Thus, the roles of Cdc13 and Est1 in modulating telomerase activity were clearly defined using the in vitro reconstituted system.

Identifiers

PMID27659693
PMCPMC5034320
OpenAlexW2522439502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.